INVESTMENT FOCUS
Two Sectors. Total Commitment.
We invest at the intersection of scientific breakthrough and commercial viability — with the patience and conviction required to build category leaders from Asia to the world.
Sector I
Life Sciences
We back companies operating at the frontier of human health — from novel therapeutic platforms and precision medicine to next-generation diagnostics and medical devices.
Our particular strength lies in the China life sciences ecosystem, where deep regulatory knowledge, scientific network, and market access create compounding advantage for our portfolio companies.
We approach every opportunity with a scientist's skepticism and an investor's discipline.
Biopharmaceuticals
Novel therapeutic modalities, biologics, and small molecule programs across oncology, metabolic, and rare disease indications in Asia and globally.
Medical Devices
Minimally invasive surgical systems, digital health infrastructure, and connected patient monitoring platforms
Diagnostics & Genomics
Next-generation sequencing applications, liquid biopsy platforms, and AI-enabled diagnostic tools with clinical utility.
Healthcare Technology
Digital therapeutics, hospital digitization, and healthcare AI systems enabling better outcomes at scale.
How We Invest
We follow a disciplined, research-driven investment process focused on identifying and scaling breakthrough companies. Our approach combines deep technical evaluation, long-term conviction, and active partnership with founders to unlock global growth
1
Research-First
Our dual positioning in Asia and global markets enables us to unlock partnerships, licensing deals, and capital introductions that single-geography investors cannot access.
2
Strategic Advisory
We embed as partners — providing access to our network, operational expertise, regulatory guidance, and cross-border market intelligence at each stage of growth.
3
The Bridge
Our dual positioning in Asia and global markets enables us to unlock partnerships, licensing deals, and capital introductions that single-geography investors cannot access.
Artificial Intelligence
Applied AI in high-value verticals — scientific discovery, industrial process optimization, and enterprise intelligence where the data advantage is structural.
Deep Tech & Materials
Advanced materials, photonics, and quantum-adjacent platforms where Asia's manufacturing ecosystem delivers defensible global advantage.
Clean Technology
Energy transition technologies with a commercial pathway — battery innovation, green hydrogen, and sustainable industrial processes.
Industrial Innovation
Robotics, precision manufacturing systems, and automation platforms that leverage Asia's engineering and supply chain leadership.
Sector II
Advanced
We invest in companies building at the hard frontier of technology — where significant capital requirements, long development timelines, and deep technical barriers create durable competitive moats.
Asia, and China in particular, is producing world-class innovation in these sectors at a pace that outstrips Western perception. We are uniquely positioned to identify these companies and accelerate their global journey.
The best deep tech companies are built slowly, but scaled globally.
